By Dr .Muhammad Mosleh Uddin
âĸ
20 Aug, 2026
Folic acid and Blood transfusion in Thalassemia
đ´ āĻā§āύ Folic acid āĻĻā§āĻā§āĻž āĻšā§?
Thalassemia-āϤ⧠chronic extravascular hemolysis āĻšā§ (in spleen) + increased erythropoiesis āĻšā§ (in bone marrow and extramedullary sites).
āĻ
āϰā§āĻĨāĻžā§ āĻāĻāĻžāύā§,
đ RBC destruction â
đ bone marrow āϤ⧠RBC production â â DNA synthesis āĻāϰ demand â â folate requirement â
āĻāĻāĻžāĻ āĻŽā§āϞ āĻāĻĨāĻžāĨ¤ āĻ
āϰā§āĻĨāĻžā§ āĻāĻāĻžāύ⧠āĻāĻŽāĻžāϰ āĻāĻĒāύāĻžāϰ āĻāĻžāĻāϤ⧠āĻĒā§āĻļā§āύā§āĻā§āϰ Folate requirement āĻŦā§āĻļāĻŋ āĻĨāĻžāĻā§ āĻ
āύā§āĻāĨ¤
āϤāĻžāĻ Baseline folate deficiency āύāĻž āĻĨāĻžāĻāϞā§āĻ āĻāĻŽāϰāĻž āĻāĻāύā§āϝ folic acid supplementation āĻĻāĻŋā§ā§ āĻĻā§āĻ particularly in patients with significant ineffective erythropoiesis/hemolysis.
đ´ Folic acid iron āύā§, āϤāĻžāĻ āĻāĻāĻŋ iron overload āĻŦāĻžā§āĻžā§ āύāĻžāĨ¤
đ´ āϤāĻžāĻšāϞ⧠blood transfusion āĻā§āύ āĻĻā§āĻ?
āĻāĻāĻžāύ⧠transfusion-āĻāϰ āĻāĻĻā§āĻĻā§āĻļā§āϝ āĻšāϞ⧠functional RBC supply āĻĻā§āĻā§āĻž, iron āĻĻā§āĻā§āĻž āύā§āĨ¤ āĻāĻžāϰāĻŖ āĻāĻāĻžāύ⧠RBC āĻāϰ life span āĻāĻŽā§ āϝāĻžā§āĨ¤ āϤāĻžāϰāĻž ⧧⧍ā§Ļ āĻĻāĻŋāύā§āϰ āĻāĻā§āĻ Damage āĻšā§ā§ āϝāĻžā§āĨ¤ āϤāĻžāĻ āĻāĻĒāύāĻŋ āĻāĻāĻžāύ⧠Iron āĻĻāĻŋā§ā§ RBC production āĻŦāĻžā§āĻŋā§ā§āĻ āϞāĻžāĻ āύā§āĻ, āĻāĻžāϰāĻŖ āĻāĻĒāύāĻžāϰ āĻĻā§ā§āĻž Iron āĻā§ āĻĻāĻŋā§ā§ āĻ āĻŋāĻāĻ Defective Hb āĻ āϤā§āϰāĻŋ āĻšāĻŦā§āĨ¤ āĻāϰ āĻāĻ āĻāĻ defective Hb containing RBC āĻĻā§āϰā§āϤ Spleen āĻ āĻāĻŋā§ā§ damage āĻšā§ā§ āϝāĻžāĻŦā§āĨ¤ āĻĢāϞ⧠āύāĻŋāĻ Hb āĻŦāĻžā§āĻŦā§āύāĻž, āĻāϞāĻā§ Iron overload āĻšāĻŦā§āĨ¤
āϤāĻžāĻ āĻāĻāĻžāύ⧠Regular packed RBC transfusion āĻāϰāϞā§:
Hb â â tissue oxygenation â â hypoxia â â erythropoietin drive â â ineffective erythropoiesis and marrow expansion â
đ´ āĻļā§āϧ⧠folic acid āĻĻāĻŋā§ā§ āĻāĻ severe anemia correct āĻāϰāĻž āϝāĻžā§ āύāĻžāĨ¤ āϤāĻžāĻ Hb <7 g/dL āĻšāϞ⧠āĻāĻŽāϰāĻž Packed RBC transfusion āĻļā§āϰ⧠āĻāϰāĻŋāĨ¤
āϤāĻŦā§ āĻāĻŋāĻā§ āĻāĻŋāĻā§ clinical context āĻ āĻāϰ⧠āĻāĻā§āĻ āĻļā§āϰ⧠āĻāϰāĻŋāĨ¤ āϝā§āĻŽāύ:
- symptomatic anemia
- poor growth/failure to thrive
- significant bone changes/pathological fractures from marrow expansion
- clinically significant extramedullary hematopoiesis.
āĻāĻŦāĻ āĻāĻā§āώā§āϤā§āϰ⧠āĻāĻŽāϰāĻž Hb level 9.5-10.5 g/dL āĻāϰ āĻŽāϧā§āϝ⧠maintain āĻāϰāĻžāϰ āĻā§āώā§āĻāĻž āĻāϰāĻŋ āĻāϞāĻšāĻžāĻŽāĻĻā§āϞāĻŋāϞā§āϞāĻžāĻšāĨ¤ āĻāĻžāϰāĻŖ transfusion āĻāϰ⧠Hb level āĻŦā§āĻļāĻŋ āĻŦāĻžā§āĻžāϤ⧠āĻā§āϞ⧠āĻāĻŦāĻžāϰ iron overload āĻāϰ āĻā§āĻāĻāĻŋ āĻāĻā§āĨ¤ āϤāĻžāĻ āϝāϤāĻā§āĻā§ minimum āĻāĻŽāĻžāĻĻā§āϰ āĻĻāϰāĻāĻžāϰ āϤāϤāĻā§āĻā§āĻ maintain āĻāϰāĻžāϰ āĻā§āώā§āĻāĻž āĻāϰāĻŋ āĻāĻŽāϰāĻž āĻāϞāĻšāĻžāĻŽāĻĻā§āϞāĻŋāϞā§āϞāĻžāĻšāĨ¤
đ´ āĻāĻāύ āĻāĻĒāύāĻžāϰ āĻĒā§āϰāĻļā§āύ, āĻāĻŋāύā§āϤ⧠transfusion āĻāϰāϞ⧠āϤ⧠Iron overload āĻšāĻŦā§?
āĻšā§āϝāĻžāĻ, āĻšāĻŦā§āĨ¤ āĻāĻāĻžāĻ major complication of chronic transfusion. āĻāĻ āĻāĻāύāĻŋāĻ packed RBC-āĻāϰ āϏāĻā§āĻā§ āĻāύā§āĻŽāĻžāύāĻŋāĻ 200â250 mg elemental iron āĻāϏā§āĨ¤ āĻļāϰā§āϰā§āϰ physiologic iron excretion āĻā§āĻŦ āϏā§āĻŽāĻŋāϤāĨ¤ āϤāĻžāĻ,
Repeated transfusion â cumulative iron â â iron overload â hemosiderosis â cardiac/liver/endocrine damage
āϤāĻžāĻ transfusion-dependent thalassemia-āϤ⧠transfusion-āĻāϰ āϏāĻā§āĻā§ iron chelation therapy āϞāĻžāĻā§āĨ¤
đ´ Examples:
Deferasirox
Deferiprone
Desferrioxamine (Deferoxamine)
đ´ Summary
đFolic acid â increased erythropoiesis āĻāϰ nutritional support.
đBlood transfusion â severe anemia correction + ineffective erythropoiesis suppression
đIron chelator â transfusion-induced iron overload prevents/treat
đ´ Note:
Thalassemia patient āĻā§ routine iron supplementation āĻĻā§āĻā§āĻž āĻāĻāĻŋāϤ āύā§, unless laboratory-confirmed iron deficiency āĻĨāĻžāĻā§āĨ¤ āĻāĻžāϰāĻŖ āĻāϤ⧠āĻāĻĒāύāĻŋ āĻĒā§āĻļā§āύā§āĻā§āϰ iron overload āĻŦāĻžā§āĻŋā§ā§ āĻĻāĻŋāĻā§āĻā§āύ āĻāϞāĻā§āĨ¤ āĻāĻŋāύā§āϤ⧠Hb āϤā§āĻŽāύ āĻāĻāĻāĻž āĻŦāĻžā§āĻŦā§ āύāĻžāĨ¤
References:
Davidson's Principles and Practice of Medicine
Hoffbrand's Essential Haematology
Williams Hematology
Thalassaemia International Federation (TIF) Guidelines
đFeel the MEDICINE
Dr. Muhammad Mosleh Uddin
MBBS (CMC), FCPS trainee (Cardiology)
Chittagong medical college & hospital